ZINGAROPOLI, MARIA ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.356
EU - Europa 1.340
AS - Asia 496
AF - Africa 19
SA - Sud America 11
OC - Oceania 1
Totale 3.223
Nazione #
US - Stati Uniti d'America 1.339
IT - Italia 700
SG - Singapore 254
RO - Romania 202
SE - Svezia 197
IN - India 98
CN - Cina 76
DE - Germania 63
ID - Indonesia 45
FI - Finlandia 43
BG - Bulgaria 32
IE - Irlanda 22
GB - Regno Unito 20
FR - Francia 17
CA - Canada 14
NL - Olanda 13
RU - Federazione Russa 11
TG - Togo 11
MY - Malesia 8
UA - Ucraina 6
AR - Argentina 5
BR - Brasile 5
HK - Hong Kong 4
MK - Macedonia 4
CZ - Repubblica Ceca 3
MX - Messico 3
TR - Turchia 3
BE - Belgio 2
JP - Giappone 2
NG - Nigeria 2
PH - Filippine 2
SA - Arabia Saudita 2
SC - Seychelles 2
AL - Albania 1
AU - Australia 1
BJ - Benin 1
BO - Bolivia 1
ES - Italia 1
IL - Israele 1
LT - Lituania 1
MA - Marocco 1
PK - Pakistan 1
PL - Polonia 1
RS - Serbia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 3.223
Città #
Rome 308
Singapore 192
Horia 186
Chandler 184
Fairfield 138
Ashburn 120
Woodbridge 63
Milan 60
Cambridge 51
Santa Clara 50
Houston 48
Seattle 45
Jakarta 44
Princeton 42
Wilmington 42
Dearborn 41
San Paolo di Civitate 32
Sofia 32
New York 31
Lawrence 26
Helsinki 24
Fremont 21
Millbury 20
Beijing 19
Dublin 19
Plano 18
Boston 17
Ann Arbor 16
Munich 14
San Diego 14
Padova 13
Boardman 11
Lomé 11
Stockholm 11
London 10
Naples 10
Andover 9
San Mateo 9
Lappeenranta 8
Los Angeles 8
Shanghai 8
Moscow 7
Toronto 7
Vignola 6
Ascoli Piceno 5
Federal 5
Hyderabad 5
Norwalk 5
Ottawa 5
Phoenix 5
Artena 4
Deiva Marina 4
Delhi 4
Florence 4
Guangzhou 4
Hong Kong 4
Lamezia Terme 4
Latina 4
Licenza 4
Mannheim 4
Paris 4
Porto Recanati 4
Pune 4
Redwood City 4
Sabaudia 4
Amsterdam 3
Brno 3
Bühl 3
Chapel Hill 3
Des Moines 3
Falkenstein 3
Frabosa Sottana 3
Frankfurt am Main 3
Hebei 3
Hefei 3
Lidköping 3
Pocapaglia 3
Portland 3
Venezia 3
Abuja 2
Araras 2
Arielli 2
Bari 2
Bologna 2
Bonita Springs 2
Brussels 2
Casamassima 2
Crevalcore 2
Falls Church 2
Ferrara 2
Fiumicino 2
Fuzhou 2
Gelsenkirchen 2
Genoa 2
Genova 2
Grafing 2
Jundiaí 2
Kunming 2
Mahé 2
Mexico City 2
Totale 2.219
Nome #
FECAL MICROBIOTA TRANSPLANTATION VIA ENEMA FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION MODULATES THE INFLAMMATORY HOST RESPONSE AND RESTORE INTESTINAL DYSBIOSIS 177
Fecal microbial transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent clostridium difficile infection patients 150
Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis 119
Reactivation of hepatitis B virus with immune-escape mutations after ocrelizumab treatment for multiple sclerosis 96
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients 94
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 91
Human polyomavirus JC replication and non coding control region analysis in multiple sclerosis patients under natalizumab treatment 89
Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical hiv-associated atherosclerosis 88
Higher levels of osteoprotegerin and immune activation/immunosenescence markers are correlated with concomitant bone and endovascular damage in HIV-suppressed patients 85
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study 84
Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation 79
Archetype and rearranged non-coding control regions (NCCR) in urothelial bladder carcinoma of immunocompetent individuals 79
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis 76
Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia 76
Major reduction of NKT cells in patients with severe COVID-19 pneumonia 73
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality 70
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study 68
Modificazioni immunofenotipiche dei linfociti T in pazienti affetti da sclerosi multipla in trattamento con natalizumab: implicazioni per la riattivazione del JC virus 66
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus 65
Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment 65
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease 64
Comparison of FTD SARS-CoV-2 Assay and RealStar RT-PCR kit 1.0 for the detection of SARS-CoV-2 61
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia 59
CD49d expression on T lymphocytes and CD8 effector percentage as predictors of JC virus reactivation in multiple sclerosis patients on natalizumab treatment. 57
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis? 57
HIV-associated progressive multifocal leukoencephalopathy. Current perspectives 54
Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients 51
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine 50
PaO2/FiO2 ratio forecasts COVID-19 patients’ outcome regardless of age: a cross-sectional, monocentric study 49
Evaluation of the anti-proliferative activity of violacein, a natural pigment of bacterial origin, in urinary bladder cancer cell lines 49
Evaluation of immunogenicity to three doses of the SARS-CoV-2 BNT162b2 mRNA vaccine in lung transplant patients 48
Human Polyomavirus JC monitoring and CD49d expression in dynamic cohorts of multiple sclerosis patients treated with natalizumab: an observational study. 46
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose 45
Small fibre neuropathy frequently underlies the painful long-COVID syndrome 45
Neuro-axonal damage and alteration of blood-brain barrier integrity in COVID-19 patients 44
Human Polyomavirus JC monitoring in dynamic cohorts of multiple sclerosis patients treated with natalizumab: an observational study 42
COVID-19 affects serum brain-derived neurotrophic factor and neurofilament light chain in aged men. Implications for morbidity and mortality 41
Blood biomarkers from the emergency department disclose severe omicron covid-19-associated outcomes 41
Polyomaviruses NCCR sequence analysis in urothelial bladder carcinoma of immunocompetent individuals. 40
Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection 40
Neurofilament assessment in patients with cervical dystonia 40
Breakthrough infections after Covid-19 vaccinations do not elicit platelet hyper-activation and associate with high platelet-lymphocyte and low platelet-neutrophil aggregates 39
Systemic, mucosal immune activation and psycho-sexual health in art-suppressed women living with HIV. Evaluating biomarkers and environmental stimuli 38
B- and T-cell responses after SARS-CoV-2 vaccination in patients with multiple sclerosis receiving disease modifying therapies. Immunological patterns and clinical implications 38
Quality of t-cell response to SARS-CoV-2 mrrna vaccine in art-treated plwh 37
Determinanti di salute: nuovi percorsi per la ricerca scientifica 35
null 35
Biomarkers of neurological damag. From acute stage to post-acute sequelae of covid-19 33
Evaluation of BAFF, APRIL and CD40L in ocrelizumab-treated pwMS and infectious risk 32
Longitudinal virological and immunological profile in a case of human monkeypox infection 32
Hepatitis B-related hepatic flare during immune reconstitution syndrome after antiretroviral treatment initiation in an HBV surface antigen-positive patient with HIV. Viroimmunological and histological characterization 30
null 30
Immunogenicity and efficacy of vaccination in people living with human immunodeficiency virus 29
null 27
Tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) and pulmonary involvement in COVID-19 pneumonia 26
Neurofilament expression as a biomarker of post-COVID-19 sudden sensorineural hearing loss 22
Baseline myeloid and lymphoid activation markers can predict time to viral load reduction under 50 copies/mL and CD4 recovery, respectively, after highly active antiretroviral therapy initiation 21
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection 21
The impact of Cytomegalovirus infection on natural killer and CD8+ t cell phenotype in multiple sclerosis 20
Blood count and renal functionality assessments in the emergency section disclose morbidity and ortality in omicron COVID-19 patients: a retrospective study 19
Impact of ifn-free and ifn-based treatment on blood myeloid dendritic cell, monocyte, slan-dc, and activated t lymphocyte dynamics during hcv infection 18
The long-term Immunogenicity of mRNABNT162b third vaccine dose in solid organ transplant recipients 17
Cardiovascular risk in HIV-positive subjects: analyses of T-cell phenotype and CD49d expression 16
Insights into Long COVID: Unraveling Risk Factors, Clinical Features, Radiological Findings, Functional Sequelae and Correlations: A Retrospective Cohort Study 15
Totale 3.443
Categoria #
all - tutte 13.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020238 0 0 0 0 0 57 49 26 35 43 16 12
2020/2021366 12 21 11 184 3 27 3 6 27 42 11 19
2021/2022564 9 8 55 48 54 28 42 44 50 29 133 64
2022/2023738 92 135 72 64 89 73 24 57 40 12 49 31
2023/2024658 19 51 19 73 76 110 13 59 14 95 45 84
2024/2025610 50 88 92 158 119 103 0 0 0 0 0 0
Totale 3.443